heptakis(2,6-o-dimethyl)beta-cyclodextrin and Osteoporosis

heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with Osteoporosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Miyamoto, K; Nishioka, T; Sakura, N; Toshima, K; Yamoto, K; Yokogawa, K	1

Other Studies

1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and Osteoporosis

Article	Year
Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol. Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:6 Topics: Administration, Intranasal; Animals; Aspartic Acid; beta-Cyclodextrins; Bone and Bones; Dose-Response Relationship, Drug; Drug Carriers; Estradiol; Female; Gas Chromatography-Mass Spectrometry; Mice; Mice, Inbred Strains; Molecular Structure; Osteoporosis; Ovariectomy; Prodrugs; Time Factors; Tissue Distribution	2006

Article

Year

Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol.

Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:6

Topics: Administration, Intranasal; Animals; Aspartic Acid; beta-Cyclodextrins; Bone and Bones; Dose-Response Relationship, Drug; Drug Carriers; Estradiol; Female; Gas Chromatography-Mass Spectrometry; Mice; Mice, Inbred Strains; Molecular Structure; Osteoporosis; Ovariectomy; Prodrugs; Time Factors; Tissue Distribution

2006